Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Science Translational Medicine
|
July 27, 2018
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio, Eric K Hoffman, Emily M Rocha, et al.
Human Gene Therapy
|
December 21, 2021
Biodistribution and Tolerability of AAV-PHP.B-CBh-<i>SMN1</i> in Wistar Han Rats and Cynomolgus Macaques Reveal Different Toxicologic Profiles
Xavier Palazzi, Ingrid D Pardo, Madhu P Sirivelu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 6, 2010
Pharmacodynamics and pharmacokinetics of the gamma-secretase inhibitor PF-3084014
Thomas A Lanz, Kathleen M Wood, Karl E G Richter, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 22, 2006
Concentration-dependent modulation of amyloid-beta in vivo and in vitro using the gamma-secretase inhibitor, LY-450139
Thomas A Lanz, Michael J Karmilowicz, Kathleen M Wood, et al.
Nature Neuroscience
|
October 24, 2020
Activated microglia cause metabolic disruptions in developmental cortical interneurons that persist in interneurons from individuals with schizophrenia
Gun-Hoo Park, Haneul Noh, Zhicheng Shao, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2026
Circulating exhausted CD8+ effector memory cells differentiate immune checkpoint inhibitor-induced liver injury from other acute immune-mediated liver injuries
Stuart Astbury, Edmond Atallah, Jane I Grove, et al.
Forest Policy and Economics
|
March 7, 2020
Assessing forest availability for wood supply in Europe
I Alberdi, S Bender, T Riedel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 4, 2023
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6<sup>+</sup> T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation
Wei Li, Kimberly K Crouse, Jennifer Alley, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 29, 2011
Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014
Michael A Brodney, David D Auperin, Stacey L Becker, et al.
Human Gene Therapy
|
July 25, 2024
Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article
Jan C Klapwijk, Alberto Del Rio Espinola, Silvana Libertini, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Science Translational Medicine
|
July 27, 2018
LRRK2 activation in idiopathic Parkinson's disease
Roberto Di Maio, Eric K Hoffman, Emily M Rocha, et al.
Human Gene Therapy
|
December 21, 2021
Biodistribution and Tolerability of AAV-PHP.B-CBh-<i>SMN1</i> in Wistar Han Rats and Cynomolgus Macaques Reveal Different Toxicologic Profiles
Xavier Palazzi, Ingrid D Pardo, Madhu P Sirivelu, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 6, 2010
Pharmacodynamics and pharmacokinetics of the gamma-secretase inhibitor PF-3084014
Thomas A Lanz, Kathleen M Wood, Karl E G Richter, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 22, 2006
Concentration-dependent modulation of amyloid-beta in vivo and in vitro using the gamma-secretase inhibitor, LY-450139
Thomas A Lanz, Michael J Karmilowicz, Kathleen M Wood, et al.
Nature Neuroscience
|
October 24, 2020
Activated microglia cause metabolic disruptions in developmental cortical interneurons that persist in interneurons from individuals with schizophrenia
Gun-Hoo Park, Haneul Noh, Zhicheng Shao, et al.
Journal for Immunotherapy of Cancer
|
March 27, 2026
Circulating exhausted CD8+ effector memory cells differentiate immune checkpoint inhibitor-induced liver injury from other acute immune-mediated liver injuries
Stuart Astbury, Edmond Atallah, Jane I Grove, et al.
Forest Policy and Economics
|
March 7, 2020
Assessing forest availability for wood supply in Europe
I Alberdi, S Bender, T Riedel, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 4, 2023
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6<sup>+</sup> T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation
Wei Li, Kimberly K Crouse, Jennifer Alley, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 29, 2011
Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014
Michael A Brodney, David D Auperin, Stacey L Becker, et al.
Human Gene Therapy
|
July 25, 2024
Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article
Jan C Klapwijk, Alberto Del Rio Espinola, Silvana Libertini, et al.
Page
of 8